Realising the potential of correlates of protection for vaccine development, licensure and use: short summary

Deborah F. King,Helen Groves,Charlie Weller,Ian Jones,Jakob P. Cramer,Peter B. Gilbert,David Goldblatt,Marion F. Gruber,Beate Kampmann,Diadié Maïga,Marcela F. Pasetti,Stanley A. Plotkin,Alexander Precioso,Liya Wassie,Frederick Wittke,David C. Kaslow

DOI: https://doi.org/10.1038/s41541-024-00872-6

2024-04-30

npj Vaccines

Abstract:On 27–29th of September 2022, Wellcome convened an international multi-stakeholder workshop to discuss the use of Correlates of Protection (CoP) to accelerate vaccine development, the hybrid format meeting was attended by 80 delegates including developers, manufacturers, regulators, public health officials and policy-makers from 17 countries, including 7 LMIC's.

immunology,medicine, research & experimental